244 related articles for article (PubMed ID: 23398365)
21. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.
Uzawa A; Mori M; Arai K; Sato Y; Hayakawa S; Masuda S; Taniguchi J; Kuwabara S
Mult Scler; 2010 Dec; 16(12):1443-52. PubMed ID: 20739337
[TBL] [Abstract][Full Text] [Related]
22. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.
Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X
Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
Yang Y; Huang DH; Wu L; Wu WP
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
[TBL] [Abstract][Full Text] [Related]
24. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
25. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
[TBL] [Abstract][Full Text] [Related]
26. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.
de Seze J; Lebrun C; Stojkovic T; Ferriby D; Chatel M; Vermersch P
Mult Scler; 2003 Oct; 9(5):521-5. PubMed ID: 14582780
[TBL] [Abstract][Full Text] [Related]
27. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
28. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica.
Zhang B; Jiang Y; Yang Y; Peng F; Hu X
Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders.
Ulusoy C; Tüzün E; Kürtüncü M; Türkoğlu R; Akman-Demir G; Eraksoy M
Int J Neurosci; 2012 Jun; 122(6):284-9. PubMed ID: 22176581
[TBL] [Abstract][Full Text] [Related]
30. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
[TBL] [Abstract][Full Text] [Related]
31. Relationship between serum bilirubin levels and optic neuritis.
Deng J; Liang XM; Zhang XL; Ling SQ; Yang TT; Li M; Peng FH
Chin Med J (Engl); 2013; 126(17):3307-10. PubMed ID: 24033954
[TBL] [Abstract][Full Text] [Related]
32. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R
Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201
[TBL] [Abstract][Full Text] [Related]
33. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
34. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X
J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277
[TBL] [Abstract][Full Text] [Related]
35. Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Shin JG; Kim HJ; Park BL; Bae JS; Kim LH; Cheong HS; Shin HD
J Neurol Sci; 2013 Dec; 335(1-2):82-8. PubMed ID: 24135429
[TBL] [Abstract][Full Text] [Related]
36. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
[TBL] [Abstract][Full Text] [Related]
37. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity.
Pei S; Zheng D; Wang Z; Hu X; Pan S; Wang H
Cytokine; 2018 Nov; 111():140-145. PubMed ID: 30142535
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
[TBL] [Abstract][Full Text] [Related]
39. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
